Glioma is one of the most aggressive malignant primary brain tumors. A common feature of glioma is the presence of localized, intermittent seizures referred to as glioma-related epilepsy, which is ...

Tumors from patients who suffer from glioma-related epilepsy can interfere with the ability of surrounding neurons to handle potassium. genprowebdirectory Facebook Linkedin RSS Twitter Youtube ...

Glioma, one of the most aggressive malignant brain tumors, ... New insights into the drivers of glioma-related epilepsy. Baylor College of Medicine. Journal Neuron DOI 10.1016/j.neuron.2023.01.013.

Glioma is a type of brain cancer. ... The relative survival rate is the calculated estimate of how long someone with a condition may live after their diagnosis compared to someone without the ...

WEDNESDAY, May 21, 2025 (HealthDay News) -- For patients with diffuse gliomas, tumor-related epilepsy (TRE) is not a strong prognostic factor, according to a study published in the May issue of ...

Researchers have discovered that an FDA-approved epilepsy drug can prevent or slow the growth of NF1-linked optic gliomas in mice, laying the groundwork for a clinical trial.

The dual IDH1–IDH2 inhibitor vorasidenib more than doubled time to progression (relative to placebo) and thus represents the first new treatment in decades for patients with glioma.

Glioma is one of the most aggressive malignant primary brain tumors. A common feature of glioma is the presence of localized, intermittent seizures referred to as glioma-related epilepsy, which is ...

Researchers at Washington University School of Medicine in St. Louis have discovered that an FDA-approved epilepsy drug can prevent or slow the growth of NF1-linked optic gliomas in mice, laying ...